Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma. (Q40610299)
Jump to navigation
Jump to search
scientific article published on 4 December 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma. |
scientific article published on 4 December 2003 |
Statements
Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma (English)
Maura Agostini
Mark Gurnell
Emily M Wood
Odelia Rajanayagam
Keith T Garnes
Sidney H Levinson
H Eric Xu
Timothy M Willson
V Krishna Chatterjee
4 December 2003